Brown Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1M | Buy |
199,765
+2,946
| +1% | +$172K | 0.02% | 397 |
|
|
2025
Q4 | $10.6M | Sell |
196,819
-23,582
| -11% | -$1.13M | 0.01% | 417 |
|
|
2025
Q3 | $9.94M | Buy |
220,401
+1,223
| +0.6% | +$57.1K | 0.01% | 420 |
|
|
2025
Q2 | $10.1M | Sell |
219,178
-1,867
| -0.8% | -$91.6K | 0.01% | 406 |
|
|
2025
Q1 | $13.5M | Sell |
221,045
-3,355
| -1% | -$196K | 0.02% | 360 |
|
|
2024
Q4 | $12.7M | Sell |
224,400
-3,973
| -2% | -$222K | 0.02% | 386 |
|
|
2024
Q3 | $11.8M | Sell |
228,373
-3,524
| -2% | -$165K | 0.01% | 398 |
|
|
2024
Q2 | $9.63M | Buy |
231,897
+9,744
| +4% | +$436K | 0.01% | 420 |
|
|
2024
Q1 | $12M | Sell |
222,153
-2,295
| -1% | -$117K | 0.02% | 394 |
|
|
2023
Q4 | $11.5M | Sell |
224,448
-17,057
| -7% | -$895K | 0.02% | 389 |
|
|
2023
Q3 | $14M | Sell |
241,505
-2,133
| -0.9% | -$131K | 0.02% | 352 |
|
|
2023
Q2 | $15.6M | Sell |
243,638
-8,248
| -3% | -$553K | 0.02% | 340 |
|
|
2023
Q1 | $17.5M | Buy |
251,886
+1,725
| +0.7% | +$122K | 0.03% | 330 |
|
|
2022
Q4 | $18M | Buy |
250,161
+4,051
| +2% | +$305K | 0.03% | 324 |
|
|
2022
Q3 | $17.5M | Buy |
246,110
+29,673
| +14% | +$2.15M | 0.03% | 321 |
|
|
2022
Q2 | $16.7M | Buy |
216,437
+6,376
| +3% | +$486K | 0.03% | 321 |
|
|
2022
Q1 | $15.3M | Sell |
210,061
-34,750
| -14% | -$2.33M | 0.02% | 345 |
|
|
2021
Q4 | $15.3M | Buy |
244,811
+29,247
| +14% | +$1.72M | 0.02% | 357 |
|
|
2021
Q3 | $12.8M | Sell |
215,564
-1,369
| -0.6% | -$90.2K | 0.02% | 346 |
|
|
2021
Q2 | $14.5M | Buy |
216,933
+5,395
| +3% | +$352K | 0.02% | 336 |
|
|
2021
Q1 | $13.4M | Sell |
211,538
-3,011
| -1% | -$187K | 0.02% | 314 |
|
|
2020
Q4 | $13.3M | Sell |
214,549
-4,746
| -2% | -$292K | 0.02% | 300 |
|
|
2020
Q3 | $13.2M | Sell |
219,295
-8,091
| -4% | -$487K | 0.03% | 280 |
|
|
2020
Q2 | $13.4M | Buy |
227,386
+2,550
| +1% | +$153K | 0.03% | 272 |
|
|
2020
Q1 | $12.5M | Buy |
224,836
+21,043
| +10% | +$1.29M | 0.04% | 249 |
|
|
2019
Q4 | $13.1M | Buy |
203,793
+14,726
| +8% | +$843K | 0.03% | 293 |
|
|
2019
Q3 | $9.59M | Sell |
189,067
-5,042
| -3% | -$237K | 0.03% | 324 |
|
|
2019
Q2 | $8.8M | Sell |
194,109
-34,358
| -15% | -$1.6M | 0.03% | 333 |
|
|
2019
Q1 | $10.9M | Sell |
228,467
-6,731
| -3% | -$335K | 0.03% | 338 |
|
|
2018
Q4 | $12.2M | Sell |
235,198
-31,595
| -12% | -$1.7M | 0.04% | 299 |
|
|
2018
Q3 | $16.6M | Sell |
266,793
-6,345
| -2% | -$377K | 0.05% | 275 |
|
|
2018
Q2 | $15.1M | Sell |
273,138
-26,033
| -9% | -$1.41M | 0.05% | 268 |
|
|
2018
Q1 | $18.9M | Sell |
299,171
-16,874
| -5% | -$1.09M | 0.06% | 237 |
|
|
2017
Q4 | $19.4M | Buy |
316,045
+11,901
| +4% | +$744K | 0.06% | 239 |
|
|
2017
Q3 | $19.4M | Buy |
304,144
+23,631
| +8% | +$1.38M | 0.06% | 233 |
|
|
2017
Q2 | $15.6M | Sell |
280,513
-10,655
| -4% | -$580K | 0.05% | 252 |
|
|
2017
Q1 | $15.8M | Sell |
291,168
-24,550
| -8% | -$1.35M | 0.05% | 243 |
|
|
2016
Q4 | $18.4M | Sell |
315,718
-24,851
| -7% | -$1.36M | 0.07% | 215 |
|
|
2016
Q3 | $18.4M | Sell |
340,569
-7,755,824
| -96% | -$498M | 0.06% | 210 |
|
|
2016
Q2 | $595M | Sell |
8,096,393
-428,543
| -5% | -$30.3M | 2.09% | 7 |
|
|
2016
Q1 | $545M | Sell |
8,524,936
-16,688
| -0.2% | -$1.05M | 1.88% | 14 |
|
|
2015
Q4 | $588M | Buy |
8,541,624
+433,894
| +5% | +$28.7M | 1.99% | 9 |
|
|
2015
Q3 | $480M | Buy |
8,107,730
+248,831
| +3% | +$15.8M | 1.71% | 17 |
|
|
2015
Q2 | $523M | Buy |
7,858,899
+730,906
| +10% | +$48.2M | 1.7% | 19 |
|
|
2015
Q1 | $460M | Buy |
7,127,993
+921,083
| +15% | +$57.7M | 1.46% | 27 |
|
|
2014
Q4 | $366M | Buy |
6,206,910
+5,919,161
| +2,057% | +$334M | 1.16% | 26 |
|
|
2014
Q3 | $14.7M | Buy |
287,749
+76,432
| +36% | +$3.82M | 0.05% | 225 |
|
|
2014
Q2 | $10.3M | Sell |
211,317
-11,880
| -5% | -$585K | 0.03% | 257 |
|
|
2014
Q1 | $11.6M | Buy |
223,197
+32,351
| +17% | +$1.72M | 0.04% | 241 |
|
|
2013
Q4 | $10.1M | Buy |
190,846
+59,316
| +45% | +$3.02M | 0.03% | 248 |
|
|
2013
Q3 | $6.09M | Sell |
131,530
-3,576
| -3% | -$157K | 0.02% | 290 |
|
|
2013
Q2 | $6.04M | Buy |
+135,106
| New | +$5.87M | 0.02% | 279 |
|
Other funds holding BMY
VCM
VPM
Brown Advisory's BMY Position: Q1 2026 in Review
Brown Advisory increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q1 2026, buying an estimated $172K and bringing the position to 199,765 shares worth $12.1M. The position accounts for 0.02% of the portfolio, ranked #397.
Brown Advisory first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $595M in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Brown Advisory held 199,765 shares of Bristol-Myers Squibb worth $12.1M as of Q1 2026.
- Brown Advisory bought 2,946 Bristol-Myers Squibb shares in Q1 2026, an estimated $172K.
- Bristol-Myers Squibb made up 0.02% of Brown Advisory's portfolio in Q1 2026, its #397 holding.
- Brown Advisory first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Brown Advisory's Bristol-Myers Squibb position peaked at $595M in Q2 2016.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.